LivaNova Enters into Binding Letter of Intent to Sell its Cardiac Rhythm Management Business Franchise to MicroPort Scientific Corporation for $190 Million

LivaNova and MicroPort Scientific Corp today announced the sale of LivaNova’s Cardiac Rhythm Management Business Franchise to MicroPort for $190 million in cash.